Loading: 100%
CANTEL MEDICAL CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 2,337 (as per Q1 2017)no data available
Sector Medical Instruments & Equipmen, HealthcareMedical Instruments & Equipmen, Healthcareno data available
Ticker CMDno data available
Financial year endsFY ends End of Julyno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1768768492100
datesClosing price (adj.)
13.10.201795.17
11.10.201795.07
04.10.201799.04
27.09.201788.01
20.09.201788.28
13.09.201783.17
06.09.201781.70
30.08.201778.54
23.08.201776.52
16.08.201776.57
09.08.201774.66
02.08.201775.76
26.07.201775.11
19.07.201776.99
12.07.201775.55
05.07.201777.05
27.06.201776.13
20.06.201776.11
13.06.201777.14
06.06.201779.04
30.05.201776.80
23.05.201772.65
16.05.201771.35
09.05.201772.99
02.05.201774.52
25.04.201774.01
18.04.201772.99
11.04.201773.37
04.04.201777.62
28.03.201779.31
21.03.201775.64
14.03.201776.35
07.03.201783.95
28.02.201782.03
21.02.201785.23
14.02.201782.17
07.02.201778.86
31.01.201777.34
24.01.201776.34
17.01.201776.28
10.01.201779.17
03.01.201777.52
27.12.201680.02
19.12.201681.23
12.12.201684.49
05.12.201682.34
28.11.201680.86
21.11.201680.79
14.11.201674.31
07.11.201671.72
31.10.201671.10
24.10.201675.44
17.10.201675.76
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
95.17n/a
Market Capitalisation
in million USD
3,970n/a
Enterprise Value
in million USD
4,105n/a
Common Shares Outstanding
as per Oct 31, 2016
41,717,493n/a
Preferred Shares Outstanding
as per Oct 31, 2016
n/a
Average Basic Shares Outstanding
TTM
41,373,964n/a
Average Diluted Shares Outstanding
TTM
41,428,430n/a
Index Membership
n/a
Business Summary
Cantel Medical Corp is dedicated in delivering infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.
no data available
Key Financials & Ratios (all figures TTM as per Oct 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 699n/a
Gross Profit 327n/a
Operating Income 101n/a
EBITDA 127n/a
Net Profit 64n/a
Balance Sheet
Cash and Cash Equivalents 26n/a
Receivables 96n/a
Total Current Assets 231n/a
PP&E 80n/a
Total Assets 749n/a
Accounts Payable 30n/a
Current Debt 0n/a
Total Current Liabilities 95n/a
Long-Term Debt 161n/a
Total Liabilities 289n/a
Total Equity 460n/a
Cash Flow
Depreciation & Amortisation 27n/a
Change in Working Capital -11n/a
Operating Cash Flow 90n/a
Net Change in PP&E and Intangibles -24n/a
Investing Cash Flow -96n/a
Dividends Paid -5n/a
Financing Cash Flow 1n/a
Total Change in Cash -5n/a
Free Cash Flow 60n/a
Profitability Ratios
Gross Margin 46.9%n/a
Operating Margin 14.4%n/a
Net Profit Margin 9.2%n/a
Return on Equity 14.0%n/a
Return on Assets 8.6%n/a
Per Share Figures
Basic EPS 1.56n/a
Diluted EPS 1.56n/a
Sales per Share 16.89n/a
Book Value per Share 11.13n/a
FCF per Share 1.46n/a
Dividends per Share 0.12n/a
Price Multiples
Price to Earnings Ratio 61.05n/a
Price to Sales Ratio 5.64n/a
Price to Book Value 8.55n/a
Price to Free Cash Flow 65.37n/a
Valuation Metrics
EV/EBITDA 32.31n/a
EV/Sales 5.88n/a
Book to Market Value 0.12n/a
Other Ratios
Current Ratio 242.8%n/a
Liabilities to Equity Ratio 62.8%n/a
Debt to Assets Ratio 21.5%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
274
322
386
425
489
565
665
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-163
-199
-222
-242
-275
-312
-356
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
111
123
164
183
213
253
309
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-78
-91
-112
-120
-142
-173
-212
Selling, General & Administrative
-73
-85
-103
-111
-132
-159
-197
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-5
-7
-9
-9
-11
-14
-15
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
33
31
52
63
71
81
97
Non-Operating Income (Loss)
-1
-1
-4
-3
-2
-2
-3
Interest Expense, net
-1
-1
-4
-3
-2
-2
-3
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
32
30
48
60
69
78
94
Abnormal Gains (Losses)
0
0
-1
0
0
-2
0
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
32
30
48
60
69
76
94
Income Tax (Expense) Benefit, net
-12
-10
-17
-21
-25
-28
-34
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
20
20
31
39
43
48
60
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
20
20
31
39
43
48
60
Minority Interest
0
0
0
0
0
0
0
Net Income
20
20
31
39
43
48
60
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
20
20
31
39
43
48
60
Remarks
restated on Oct 15, 2012 n/a
calculated values,
restated on Sep 30, 2013 n/a
calculated values,
restated on Sep 29, 2014 n/a
calculated values,
restated on Sep 29, 2015 n/a
calculated values,
restated on Sep 29, 2016 n/a
calculated values,
restated on Sep 29, 2016 n/a
calculated values,
restated on Sep 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 75% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
18
30
34
32
32
28
Cash & Cash Equivalents
n/a
18
30
34
32
32
28
Short Term Investments
n/a
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
46
48
53
62
70
93
Accounts Receivable, Net
n/a
46
48
53
62
70
93
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
40
47
54
60
72
91
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
7
9
10
10
15
10
Prepaid Expenses
n/a
3
3
4
7
9
10
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
4
4
4
4
6
0
Income Taxes Receivable
n/a
0
2
1
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
111
134
151
164
188
223
Property, Plant & Equipment, Net
n/a
34
43
46
53
63
75
Property, Plant & Equipment
n/a
75
88
97
108
125
0
Accumulated Depreciation
n/a
-40
-45
-50
-55
-62
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
176
258
291
320
333
397
Intangible Assets
n/a
39
71
76
83
86
112
Goodwill
n/a
135
184
212
232
242
280
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
2
3
3
5
5
5
Total Noncurrent Assets
n/a
210
301
337
372
396
472
Total Assets
n/a
321
435
488
536
584
695
Liabilities and owners' equity
Payables & Accruals
n/a
37 36693000
37 37027000
38 37771000
50 50397000
52 52301000
76 76162000
Accounts Payable
n/a
13 13218000
12 12345000
13 13322000
20 19529000
16 16184000
26 26263000
Accrued Taxes
n/a
1 977000
0 0
0 0
1 893000
2 2468000
4 4061000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
22 22498000
25 24682000
24 24449000
30 29975000
34 33649000
46 45838000
Short Term Debt
n/a
0 0
10 10000000
10 10000000
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
7 6718000
8 8114000
11 11380000
16 16102000
18 18323000
20 20173000
Deferred Revenue
n/a
7 6718000
8 8114000
11 11380000
16 16102000
18 18323000
20 20173000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
43 43411000
55 55141000
59 59151000
66 66499000
71 70624000
96 96335000
Long Term Debt
n/a
24 24000000
80 80000000
85 85000000
81 80500000
79 78500000
116 116000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
20 19717000
21 21198000
22 22388000
24 23900000
28 28274000
28 27827000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
18 18450000
20 19894000
21 21186000
18 17805000
24 23722000
24 23579000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
1 1267000
1 1304000
1 1202000
6 6095000
5 4552000
4 4248000
Total Noncurrent Liabilities
n/a
44 43717000
101 101198000
107 107388000
104 104400000
107 106774000
144 143827000
Total Liabilities
n/a
87 87128000
156 156339000
167 166539000
171 170899000
177 177398000
240 240162000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
113 112651000
130 130338000
139 139371000
151 150612000
161 160641000
170 170181000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-26 -26344000
-30 -30116000
-33 -32978000
-38 -38224000
-42 -42337000
-46 -46069000
Retained Earnings
n/a
139 138725000
168 167539000
204 203762000
243 243306000
287 287105000
342 342053000
Other Equity
n/a
9 9283000
8 8175000
11 10977000
10 9552000
1 1224000
-12 -11795000
Equity Before Minority Interest
n/a
234 234315000
276 275936000
321 321132000
365 365246000
407 406633000
454 454370000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
234 234315000
276 275936000
321 321132000
365 365246000
407 406633000
454 454370000
Total Liabilities & Equity
n/a
321 321443000
432 432275000
488 487671000
536 536145000
584 584031000
695 694532000
Remarks restated on n/a restated on Oct 15, 2012 n/a restated on Sep 30, 2013 n/a restated on Sep 29, 2014 n/a restated on Sep 29, 2015 n/a restated on Sep 29, 2016 n/a restated on Dec 8, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
20
20
31
39
43
48
60
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
11
12
16
17
19
24
25
Non-Cash Items
1
1
3
-1
1
3
6
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
-4
-6
0
-4
1
-16
-11
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
29
28
51
51
64
59
80
Change in Fixed Assets & Intangibles
-6
-6
-5
-7
-14
-13
-19
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-2
-30
-98
-45
-34
-40
-95
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
-1
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-8
-36
-103
-52
-47
-52
-113
Dividends Paid
-2
-2
-3
-3
-4
-4
-5
Cash From (Repayment of) Debt
-22
3
65
5
-16
-2
38
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
2
1
0
0
-4
-3
-4
Increase in Capital Stock
2
3
2
2
1
1
0
Decrease in Capital Stock
0
-1
-2
-2
-4
-4
-4
Other Financing Activities
0
1
2
3
4
3
1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
-22
3
65
4
-19
-6
30
Net Cash Before Disc. Operations and FX
-1
-5
12
4
-2
1
-3
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
-1
-5
12
4
-2
1
-3
Effect of Foreign Exchange Rates
0
0
0
0
0
-1
-1
Net Changes in Cash
-1
-4
12
4
-2
0
-3
Remarks
restated on Oct 15, 2012 n/a
calculated values,
restated on Sep 30, 2013 n/a
calculated values,
restated on Sep 29, 2014 n/a
calculated values,
restated on Sep 29, 2015 n/a
calculated values,
restated on Sep 29, 2016 n/a
calculated values,
restated on Sep 29, 2016 n/a
calculated values,
restated on Sep 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo